2026-01-08 – Press Releases – www.prnewswire.com
MELBOURNE, Australia and INDIANAPOLIS, Jan. 8, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 44th Annual J.P. Morgan Healthcare Conference being…
